An comprehensive examination of the therapeutic and dietary attributes of Stevia
DOI:
https://doi.org/10.12775/QS.2024.16.52212Keywords
stevia, obesity, sugar substitute, artificial sweetenerAbstract
Introduction
Stevia rebaudiana, an indigenous plant of South America, is becoming increasingly popular because of its potent sweetness obtained from steviol glycosides, which are considerably sweeter than sucrose. Due to its low calorie content and this characteristic, Stevia is considered a favoured sugar alternative in a wide range of food products. In addition to being a substitute for sugar, Stevia provides a range of metabolic benefits. Studies have shown that extracts from this plant have antihypertensive and antihyperlipidemic qualities, can control blood glucose and insulin levels, enhance kidney function, and may have potential anticancer effects. The wide range of advantageous characteristics linked to Stevia highlights its promise as a subject for further exploration of its health-promoting effects. This article offers an analysis of scientific research and reliable sources, presenting the metabolic advantages and health impacts of steviol glycosides obtained from Stevia in the human body.
Aim of the study
This review aims to identify the metabolic benefits of Stevia rebaudiana on the human body. The main objective is to present its action as a component in the fight against obesity, diabetes, hypertension, dyslipidaemia and cancer cells.
Material and method
This article presents the current state of knowledge about the range of metabolic benefits of Stevia rebaudiana. Publications describing the effects of Stevia rebaudiana use on the metabolism and health of the human body were reviewed using the PubMed platform. The search included the keywords 'stevia', 'artificial sweetener', 'sugar substitute', 'obesity'.
References
Samuel P, Ayoob KT, Magnuson BA, Wölwer-Rieck U, Jeppesen PB, Rogers PJ, Rowland I, Mathews R. Stevia Leaf to Stevia Sweetener: Exploring Its Science, Benefits, and Future Potential. J Nutr. 2018 Jul 1;148(7):1186S-1205S. doi: 10.1093/jn/nxy102. PMID: 29982648.
Peteliuk V, Rybchuk L, Bayliak M, Storey KB, Lushchak O. Natural sweetener Stevia rebaudiana: Functionalities, health benefits and potential risks. EXCLI J. 2021 Sep 22;20:1412-1430. doi: 10.17179/excli2021-4211. PMID: 34803554; PMCID: PMC8600158.
Carakostas MC, Curry LL, Boileau AC, Brusick DJ. Overview: the history, technical function and safety of rebaudioside A, a naturally occurring steviol glycoside, for use in food and beverages. Food Chem Toxicol. 2008 Jul;46 Suppl 7:S1-S10. doi: 10.1016/j.fct.2008.05.003. Epub 2008 May 16. PMID: 18555576.
Carrera-Lanestosa A, Moguel-Ordóñez Y, Segura-Campos M. Stevia rebaudiana Bertoni: A Natural Alternative for Treating Diseases Associated with Metabolic Syndrome. J Med Food. 2017 Oct;20(10):933-943. doi: 10.1089/jmf.2016.0171. Epub 2017 Aug 9. PMID: 28792778; PMCID: PMC5651958.
Magnuson BA, Carakostas MC, Moore NH, Poulos SP, Renwick AG. Biological fate of low-calorie sweeteners. Nutr Rev. 2016 Nov;74(11):670-689. doi: 10.1093/nutrit/nuw032. PMID: 27753624.
Iatridis N, Kougioumtzi A, Vlataki K, Papadaki S, Magklara A. Anti-Cancer Properties of Stevia rebaudiana; More than a Sweetener. Molecules. 2022 Feb 17;27(4):1362. doi: 10.3390/molecules27041362. PMID: 35209150; PMCID: PMC8874712.
Rizwan F, Rashid HU, Yesmine S, Monjur F, Chatterjee TK. Preliminary analysis of the effect of Stevia (Stevia rebaudiana) in patients with chronic kidney disease (stage I to stage III). Contemp Clin Trials Commun. 2018 Aug 21;12:17-25. doi: 10.1016/j.conctc.2018.08.007. PMID: 30211340; PMCID: PMC6129687.
Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr. 2006 Aug;84(2):274-88. doi: 10.1093/ajcn/84.1.274. PMID: 16895873; PMCID: PMC3210834.
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999 Oct 27;282(16):1523-9. doi: 10.1001/jama.282.16.1523. PMID: 10546691.
Raben A, Vasilaras TH, Møller AC, Astrup A. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr. 2002 Oct;76(4):721-9. doi: 10.1093/ajcn/76.4.721. PMID: 12324283.
Anderson GH, Foreyt J, Sigman-Grant M, Allison DB. The use of low-calorie sweeteners by adults: impact on weight management. J Nutr. 2012 Jun;142(6):1163S-9S. doi: 10.3945/jn.111.149617. Epub 2012 May 9. PMID: 22573781.
Walbolt J, Koh Y. Non-nutritive Sweeteners and Their Associations with Obesity and Type 2 Diabetes. J Obes Metab Syndr. 2020 Jun 30;29(2):114-123. doi: 10.7570/jomes19079. PMID: 32482914; PMCID: PMC7338497.
Anton SD, Martin CK, Han H, Coulon S, Cefalu WT, Geiselman P, Williamson DA. Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite. 2010 Aug;55(1):37-43. doi: 10.1016/j.appet.2010.03.009. Epub 2010 Mar 18. PMID: 20303371; PMCID: PMC2900484.
Lailerd N, Saengsirisuwan V, Sloniger JA, Toskulkao C, Henriksen EJ. Effects of stevioside on glucose transport activity in insulin-sensitive and insulin-resistant rat skeletal muscle. Metabolism. 2004 Jan;53(1):101-7. doi: 10.1016/j.metabol.2003.07.014. PMID: 14681850.
Misra H, Soni M, Silawat N, Mehta D, Mehta BK, Jain DC. Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan-induced diabetic rats. J Pharm Bioallied Sci. 2011 Apr;3(2):242-8. doi: 10.4103/0975-7406.80779. PMID: 21687353; PMCID: PMC3103919.
Jeppesen PB, Gregersen S, Poulsen CR, Hermansen K. Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity. Metabolism. 2000 Feb;49(2):208-14. doi: 10.1016/s0026-0495(00)91325-8. PMID: 10690946.
Lee JH, Kim KI, Cho MC. Current status and therapeutic considerations of hypertension in the elderly. Korean J Intern Med. 2019 Jul;34(4):687-695. doi: 10.3904/kjim.2019.196. Epub 2019 Jul 1. PMID: 31272140; PMCID: PMC6610178.
Borghi C, Fogacci F, Agnoletti D, Cicero AFG. Hypertension and Dyslipidemia Combined Therapeutic Approaches. High Blood Press Cardiovasc Prev. 2022 May;29(3):221-230. doi: 10.1007/s40292-022-00507-8. Epub 2022 Mar 25. PMID: 35334087; PMCID: PMC9050771.
Chan P, Tomlinson B, Chen YJ, Liu JC, Hsieh MH, Cheng JT. A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Br J Clin Pharmacol. 2000 Sep;50(3):215-20. doi: 10.1046/j.1365-2125.2000.00260.x. PMID: 10971305; PMCID: PMC2014988.
Lee CN, Wong KL, Liu JC, Chen YJ, Cheng JT, Chan P. Inhibitory effect of stevioside on calcium influx to produce antihypertension. Planta Med. 2001 Dec;67(9):796-9. doi: 10.1055/s-2001-18841. PMID: 11745013.
Berberich AJ, Hegele RA. A Modern Approach to Dyslipidemia. Endocr Rev. 2022 Jul 13;43(4):611-653. doi: 10.1210/endrev/bnab037. PMID: 34676866; PMCID: PMC9277652.
Ahmad U, Ahmad RS, Arshad MS, Mushtaq Z, Hussain SM, Hameed A. Antihyperlipidemic efficacy of aqueous extract of Stevia rebaudiana Bertoni in albino rats. Lipids Health Dis. 2018 Jul 27;17(1):175. doi: 10.1186/s12944-018-0810-9. PMID: 30053819; PMCID: PMC6064095.
Onopiuk A, Tokarzewicz A, Gorodkiewicz E. Cystatin C: a kidney function biomarker. Adv Clin Chem. 2015;68:57-69. doi: 10.1016/bs.acc.2014.11.007. Epub 2015 Jan 8. PMID: 25858868.
Jung CY, Yoo TH. Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease. Diabetes Metab J. 2022 Mar;46(2):181-197. doi: 10.4093/dmj.2021.0329. Epub 2022 Mar 24. PMID: 35385633; PMCID: PMC8987689.
Melis MS. Chronic administration of aqueous extract of Stevia rebaudiana in rats: renal effects. J Ethnopharmacol. 1995 Jul 28;47(3):129-34. doi: 10.1016/0378-8741(95)01271-e. PMID: 8569236.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
Gallagher EJ, LeRoith D. Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. Physiol Rev. 2015 Jul;95(3):727-48. doi: 10.1152/physrev.00030.2014. PMID: 26084689; PMCID: PMC4491542.
Chen J, Xia Y, Sui X, Peng Q, Zhang T, Li J, Zhang J. Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively. Oncotarget. 2018 May 29;9(41):26299-26308. doi: 10.18632/oncotarget.25233. PMID: 29899860; PMCID: PMC5995179.
Gupta E, Kaushik S, Purwar S, Sharma R, Balapure AK, Sundaram S. Anticancer Potential of Steviol in MCF-7 Human Breast Cancer Cells. Pharmacogn Mag. 2017 Jul-Sep;13(51):345-350. doi: 10.4103/pm.pm_29_17. Epub 2017 Jul 19. PMID: 28839355; PMCID: PMC5551348.
Sharma A, Amarnath S, Thulasimani M, Ramaswamy S. Artificial sweeteners as a sugar substitute: Are they really safe? Indian J Pharmacol. 2016 May-Jun;48(3):237-40. doi: 10.4103/0253-7613.182888. PMID: 27298490; PMCID: PMC4899993.
Lohner S, Toews I, Meerpohl JJ. Health outcomes of non-nutritive sweeteners: analysis of the research landscape. Nutr J. 2017 Sep 8;16(1):55. doi: 10.1186/s12937-017-0278-x. PMID: 28886707; PMCID: PMC5591507.
Melis MS. Effects of chronic administration of Stevia rebaudiana on fertility in rats. J Ethnopharmacol. 1999 Nov 1;67(2):157-61. doi: 10.1016/s0378-8741(99)00081-1. PMID: 10619379.
Uçar A, Yılmaz S, Yılmaz Ş, Kılıç MS. A research on the genotoxicity of stevia in human lymphocytes. Drug Chem Toxicol. 2018 Apr;41(2):221-224. doi: 10.1080/01480545.2017.1349135. Epub 2017 Jul 24. PMID: 28738695.
Urban JD, Carakostas MC, Taylor SL. Steviol glycoside safety: are highly purified steviol glycoside sweeteners food allergens? Food Chem Toxicol. 2015 Jan;75:71-8. doi: 10.1016/j.fct.2014.11.011. Epub 2014 Nov 18. PMID: 25449199.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Zuzanna Kotowicz, Ksenia Kwaśniak, Agata Magierska, Weronika Kmiotek, Angelika Foryś, Magdalena Miłek, Mariola Banach, Monika Ślusarczyk, Weronika Stawska, Anna Niemczyk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 208
Number of citations: 0